APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Rabies Immune Globulin (HRIG)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Rabies Immune Globulin (HRIG) Market Analysis and Forecast 2026-2032

2 January 2026198 pages

Choose your research edition.

Industry ResearchHuman Rabies Immune Globulin (HRIG) Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Rabies Immune Globulin (HRIG) Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Human Rabies Immune Globulin (HRIG) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Rabies Immune Globulin (HRIG) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Rabies Immune Globulin (HRIG) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Human Rabies Immune Globulin (HRIG) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Rabies Immune Globulin (HRIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Rabies Immune Globulin (HRIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Rabies Immune Globulin (HRIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Rabies Immune Globulin (HRIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Rabies Immune Globulin (HRIG) include Bharat Serum, CBPO, CNBG, CSL Behring, Grifols, Kamada, VINS, Shuanglin Bio and Sanofi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Rabies Immune Globulin (HRIG), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Rabies Immune Globulin (HRIG), also provides the sales of main regions and countries. Of the upcoming market potential for Human Rabies Immune Globulin (HRIG), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Rabies Immune Globulin (HRIG) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Rabies Immune Globulin (HRIG) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Rabies Immune Globulin (HRIG) sales, projected growth trends, production technology, application and end-user industry.

Human Rabies Immune Globulin (HRIG) Segment by Company

Bharat Serum

CBPO

CNBG

CSL Behring

Grifols

Kamada

VINS

Shuanglin Bio

Sanofi

Shanghai RAAS

Weiguang Bio

Sichuan Yuanda Shuyang

Human Rabies Immune Globulin (HRIG) Segment by Type

200IU

500IU

Human Rabies Immune Globulin (HRIG) Segment by Application

Category II Exposure

Category III Exposure

Human Rabies Immune Globulin (HRIG) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rabies Immune Globulin (HRIG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Rabies Immune Globulin (HRIG) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rabies Immune Globulin (HRIG).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Rabies Immune Globulin (HRIG) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Rabies Immune Globulin (HRIG) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Rabies Immune Globulin (HRIG) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 200IU Major Manufacturers Table 3. 500IU Major Manufacturers Table 4. Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Category II Exposure Major Manufacturers Table 6. Category III Exposure Major Manufacturers Table 7. Human Rabies Immune Globulin (HRIG) Industry Trends Table 8. Human Rabies Immune Globulin (HRIG) Industry Drivers Table 9. Human Rabies Immune Globulin (HRIG) Industry Opportunities and Challenges Table 10. Human Rabies Immune Globulin (HRIG) Industry Restraints Table 11. Global Human Rabies Immune Globulin (HRIG) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2021-2026) Table 15. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2027-2032) Table 16. Global Human Rabies Immune Globulin (HRIG) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Tons) Table 17. Global Human Rabies Immune Globulin (HRIG) Sales by Region (2021-2026) & (K Tons) Table 18. Global Human Rabies Immune Globulin (HRIG) Sales by Region (2027-2032) & (K Tons) Table 19. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2021-2026) Table 20. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2027-2032) Table 21. Global Human Rabies Immune Globulin (HRIG) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Human Rabies Immune Globulin (HRIG) Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Manufacturers (2021-2026) Table 25. Global Human Rabies Immune Globulin (HRIG) Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 26. Global Human Rabies Immune Globulin (HRIG) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Human Rabies Immune Globulin (HRIG) Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Human Rabies Immune Globulin (HRIG) Manufacturers, Product Type & Application Table 29. Global Human Rabies Immune Globulin (HRIG) Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Human Rabies Immune Globulin (HRIG) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Human Rabies Immune Globulin (HRIG) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2021-2026) Table 36. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2027-2032) Table 37. Global Human Rabies Immune Globulin (HRIG) Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 38. Global Human Rabies Immune Globulin (HRIG) Sales by Type (2021-2026) & (K Tons) Table 39. Global Human Rabies Immune Globulin (HRIG) Sales by Type (2027-2032) & (K Tons) Table 40. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2021-2026) Table 41. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2027-2032) Table 42. Global Human Rabies Immune Globulin (HRIG) Price by Type (2021-2026) & (US$/Ton) Table 43. Global Human Rabies Immune Globulin (HRIG) Price by Type (2027-2032) & (US$/Ton) Table 44. Global Human Rabies Immune Globulin (HRIG) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2021-2026) Table 48. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2027-2032) Table 49. Global Human Rabies Immune Globulin (HRIG) Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 50. Global Human Rabies Immune Globulin (HRIG) Sales by Application (2021-2026) & (K Tons) Table 51. Global Human Rabies Immune Globulin (HRIG) Sales by Application (2027-2032) & (K Tons) Table 52. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2021-2026) Table 53. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2027-2032) Table 54. Global Human Rabies Immune Globulin (HRIG) Price by Application (2021-2026) & (US$/Ton) Table 55. Global Human Rabies Immune Globulin (HRIG) Price by Application (2027-2032) & (US$/Ton) Table 56. Bharat Serum Company Information Table 57. Bharat Serum Business Overview Table 58. Bharat Serum Human Rabies Immune Globulin (HRIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 59. Bharat Serum Human Rabies Immune Globulin (HRIG) Product Portfolio Table 60. Bharat Serum Recent Development Table 61. CBPO Company Information Table 62. CBPO Business Overview Table 63. CBPO Human Rabies Immune Globulin (HRIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 64. CBPO Human Rabies Immune Globulin (HRIG) Product Portfolio Table 65. CBPO Recent Development Table 66. CNBG Company Information Table 67. CNBG Business Overview Table 68. CNBG Human Rabies Immune Globulin (HRIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. CNBG Human Rabies Immune Globulin (HRIG) Product Portfolio Table 70. CNBG Recent Development Table 71. CSL Behring Company Information Table 72. CSL Behring Business Overview Table 73. CSL Behring Human Rabies Immune Globulin (HRIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. CSL Behring Human Rabies Immune Globulin (HRIG) Product Portfolio Table 75. CSL Behring Recent Development Table 76. Grifols Company Information Table 77. Grifols Business Overview Table 78. Grifols Human Rabies Immune Globulin (HRIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Grifols Human Rabies Immune Globulin (HRIG) Product Portfolio Table 80. Grifols Recent Development Table 81. Kamada Company Information Table 82. Kamada Business Overview Table 83. Kamada Human Rabies Immune Globulin (HRIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Kamada Human Rabies Immune Globulin (HRIG) Product Portfolio Table 85. Kamada Recent Development Table 86. VINS Company Information Table 87. VINS Business Overview Table 88. VINS Human Rabies Immune Globulin (HRIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. VINS Human Rabies Immune Globulin (HRIG) Product Portfolio Table 90. VINS Recent Development Table 91. Shuanglin Bio Company Information Table 92. Shuanglin Bio Business Overview Table 93. Shuanglin Bio Human Rabies Immune Globulin (HRIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Shuanglin Bio Human Rabies Immune Globulin (HRIG) Product Portfolio Table 95. Shuanglin Bio Recent Development Table 96. Sanofi Company Information Table 97. Sanofi Business Overview Table 98. Sanofi Human Rabies Immune Globulin (HRIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Sanofi Human Rabies Immune Globulin (HRIG) Product Portfolio Table 100. Sanofi Recent Development Table 101. Shanghai RAAS Company Information Table 102. Shanghai RAAS Business Overview Table 103. Shanghai RAAS Human Rabies Immune Globulin (HRIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Shanghai RAAS Human Rabies Immune Globulin (HRIG) Product Portfolio Table 105. Shanghai RAAS Recent Development Table 106. Weiguang Bio Company Information Table 107. Weiguang Bio Business Overview Table 108. Weiguang Bio Human Rabies Immune Globulin (HRIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Weiguang Bio Human Rabies Immune Globulin (HRIG) Product Portfolio Table 110. Weiguang Bio Recent Development Table 111. Sichuan Yuanda Shuyang Company Information Table 112. Sichuan Yuanda Shuyang Business Overview Table 113. Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Product Portfolio Table 115. Sichuan Yuanda Shuyang Recent Development Table 116. North America Human Rabies Immune Globulin (HRIG) Revenue by Type (2021-2026) & (US$ Million) Table 117. North America Human Rabies Immune Globulin (HRIG) Revenue by Type (2027-2032) & (US$ Million) Table 118. North America Human Rabies Immune Globulin (HRIG) Sales by Type (2021-2026) & (K Tons) Table 119. North America Human Rabies Immune Globulin (HRIG) Sales by Type (2027-2032) & (K Tons) Table 120. North America Human Rabies Immune Globulin (HRIG) Sales Price by Type (2021-2026) & (US$/Ton) Table 121. North America Human Rabies Immune Globulin (HRIG) Sales Price by Type (2027-2032) & (US$/Ton) Table 122. North America Human Rabies Immune Globulin (HRIG) Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Human Rabies Immune Globulin (HRIG) Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Human Rabies Immune Globulin (HRIG) Sales by Application (2021-2026) & (K Tons) Table 125. North America Human Rabies Immune Globulin (HRIG) Sales by Application (2027-2032) & (K Tons) Table 126. North America Human Rabies Immune Globulin (HRIG) Sales Price by Application (2021-2026) & (US$/Ton) Table 127. North America Human Rabies Immune Globulin (HRIG) Sales Price by Application (2027-2032) & (US$/Ton) Table 128. North America Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. North America Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. North America Human Rabies Immune Globulin (HRIG) Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 132. North America Human Rabies Immune Globulin (HRIG) Sales by Country (2021-2026) & (K Tons) Table 133. North America Human Rabies Immune Globulin (HRIG) Sales by Country (2027-2032) & (K Tons) Table 134. North America Human Rabies Immune Globulin (HRIG) Sales Price by Country (2021-2026) & (US$/Ton) Table 135. North America Human Rabies Immune Globulin (HRIG) Sales Price by Country (2027-2032) & (US$/Ton) Table 136. United States Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 137. Canada Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 138. Europe Human Rabies Immune Globulin (HRIG) Revenue by Type (2021-2026) & (US$ Million) Table 139. Europe Human Rabies Immune Globulin (HRIG) Revenue by Type (2027-2032) & (US$ Million) Table 140. Europe Human Rabies Immune Globulin (HRIG) Sales by Type (2021-2026) & (K Tons) Table 141. Europe Human Rabies Immune Globulin (HRIG) Sales by Type (2027-2032) & (K Tons) Table 142. Europe Human Rabies Immune Globulin (HRIG) Sales Price by Type (2021-2026) & (US$/Ton) Table 143. Europe Human Rabies Immune Globulin (HRIG) Sales Price by Type (2027-2032) & (US$/Ton) Table 144. Europe Human Rabies Immune Globulin (HRIG) Revenue by Application (2021-2026) & (US$ Million) Table 145. Europe Human Rabies Immune Globulin (HRIG) Revenue by Application (2027-2032) & (US$ Million) Table 146. Europe Human Rabies Immune Globulin (HRIG) Sales by Application (2021-2026) & (K Tons) Table 147. Europe Human Rabies Immune Globulin (HRIG) Sales by Application (2027-2032) & (K Tons) Table 148. Europe Human Rabies Immune Globulin (HRIG) Sales Price by Application (2021-2026) & (US$/Ton) Table 149. Europe Human Rabies Immune Globulin (HRIG) Sales Price by Application (2027-2032) & (US$/Ton) Table 150. Europe Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Europe Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. Europe Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 154. Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2021-2026) & (K Tons) Table 155. Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2027-2032) & (K Tons) Table 156. Europe Human Rabies Immune Globulin (HRIG) Sales Price by Country (2021-2026) & (US$/Ton) Table 157. Europe Human Rabies Immune Globulin (HRIG) Sales Price by Country (2027-2032) & (US$/Ton) Table 158. Germany Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 159. France Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 160. U.K. Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 161. Italy Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 162. Netherlands Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 163. China Human Rabies Immune Globulin (HRIG) Revenue by Type (2021-2026) & (US$ Million) Table 164. China Human Rabies Immune Globulin (HRIG) Revenue by Type (2027-2032) & (US$ Million) Table 165. China Human Rabies Immune Globulin (HRIG) Sales by Type (2021-2026) & (K Tons) Table 166. China Human Rabies Immune Globulin (HRIG) Sales by Type (2027-2032) & (K Tons) Table 167. China Human Rabies Immune Globulin (HRIG) Sales Price by Type (2021-2026) & (US$/Ton) Table 168. China Human Rabies Immune Globulin (HRIG) Sales Price by Type (2027-2032) & (US$/Ton) Table 169. China Human Rabies Immune Globulin (HRIG) Revenue by Application (2021-2026) & (US$ Million) Table 170. China Human Rabies Immune Globulin (HRIG) Revenue by Application (2027-2032) & (US$ Million) Table 171. China Human Rabies Immune Globulin (HRIG) Sales by Application (2021-2026) & (K Tons) Table 172. China Human Rabies Immune Globulin (HRIG) Sales by Application (2027-2032) & (K Tons) Table 173. China Human Rabies Immune Globulin (HRIG) Sales Price by Application (2021-2026) & (US$/Ton) Table 174. China Human Rabies Immune Globulin (HRIG) Sales Price by Application (2027-2032) & (US$/Ton) Table 175. Asia Human Rabies Immune Globulin (HRIG) Revenue by Type (2021-2026) & (US$ Million) Table 176. Asia Human Rabies Immune Globulin (HRIG) Revenue by Type (2027-2032) & (US$ Million) Table 177. Asia Human Rabies Immune Globulin (HRIG) Sales by Type (2021-2026) & (K Tons) Table 178. Asia Human Rabies Immune Globulin (HRIG) Sales by Type (2027-2032) & (K Tons) Table 179. Asia Human Rabies Immune Globulin (HRIG) Sales Price by Type (2021-2026) & (US$/Ton) Table 180. Asia Human Rabies Immune Globulin (HRIG) Sales Price by Type (2027-2032) & (US$/Ton) Table 181. Asia Human Rabies Immune Globulin (HRIG) Revenue by Application (2021-2026) & (US$ Million) Table 182. Asia Human Rabies Immune Globulin (HRIG) Revenue by Application (2027-2032) & (US$ Million) Table 183. Asia Human Rabies Immune Globulin (HRIG) Sales by Application (2021-2026) & (K Tons) Table 184. Asia Human Rabies Immune Globulin (HRIG) Sales by Application (2027-2032) & (K Tons) Table 185. Asia Human Rabies Immune Globulin (HRIG) Sales Price by Application (2021-2026) & (US$/Ton) Table 186. Asia Human Rabies Immune Globulin (HRIG) Sales Price by Application (2027-2032) & (US$/Ton) Table 187. Asia Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. Asia Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. Asia Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. Asia Human Rabies Immune Globulin (HRIG) Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 191. Asia Human Rabies Immune Globulin (HRIG) Sales by Country (2021-2026) & (K Tons) Table 192. Asia Human Rabies Immune Globulin (HRIG) Sales by Country (2027-2032) & (K Tons) Table 193. Asia Human Rabies Immune Globulin (HRIG) Sales Price by Country (2021-2026) & (US$/Ton) Table 194. Asia Human Rabies Immune Globulin (HRIG) Sales Price by Country (2027-2032) & (US$/Ton) Table 195. Japan Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 196. South Korea Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 197. India Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 198. Australia Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 199. China Taiwan Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 200. Southeast Asia Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 201. SAMEA Human Rabies Immune Globulin (HRIG) Revenue by Type (2021-2026) & (US$ Million) Table 202. SAMEA Human Rabies Immune Globulin (HRIG) Revenue by Type (2027-2032) & (US$ Million) Table 203. SAMEA Human Rabies Immune Globulin (HRIG) Sales by Type (2021-2026) & (K Tons) Table 204. SAMEA Human Rabies Immune Globulin (HRIG) Sales by Type (2027-2032) & (K Tons) Table 205. SAMEA Human Rabies Immune Globulin (HRIG) Sales Price by Type (2021-2026) & (US$/Ton) Table 206. SAMEA Human Rabies Immune Globulin (HRIG) Sales Price by Type (2027-2032) & (US$/Ton) Table 207. SAMEA Human Rabies Immune Globulin (HRIG) Revenue by Application (2021-2026) & (US$ Million) Table 208. SAMEA Human Rabies Immune Globulin (HRIG) Revenue by Application (2027-2032) & (US$ Million) Table 209. SAMEA Human Rabies Immune Globulin (HRIG) Sales by Application (2021-2026) & (K Tons) Table 210. SAMEA Human Rabies Immune Globulin (HRIG) Sales by Application (2027-2032) & (K Tons) Table 211. SAMEA Human Rabies Immune Globulin (HRIG) Sales Price by Application (2021-2026) & (US$/Ton) Table 212. SAMEA Human Rabies Immune Globulin (HRIG) Sales Price by Application (2027-2032) & (US$/Ton) Table 213. SAMEA Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 214. SAMEA Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 215. SAMEA Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 216. SAMEA Human Rabies Immune Globulin (HRIG) Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 217. SAMEA Human Rabies Immune Globulin (HRIG) Sales by Country (2021-2026) & (K Tons) Table 218. SAMEA Human Rabies Immune Globulin (HRIG) Sales by Country (2027-2032) & (K Tons) Table 219. SAMEA Human Rabies Immune Globulin (HRIG) Sales Price by Country (2021-2026) & (US$/Ton) Table 220. SAMEA Human Rabies Immune Globulin (HRIG) Sales Price by Country (2027-2032) & (US$/Ton) Table 221. Brazil Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 222. Argentina Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 223. Chile Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 224. Colombia Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 225. Peru Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 226. Saudi Arabia Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 227. Israel Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 228. UAE Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 229. Turkey Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 230. Iran Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 231. Egypt Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Table 232. Key Raw Materials Table 233. Raw Materials Key Suppliers Table 234. Human Rabies Immune Globulin (HRIG) Distributors List Table 235. Human Rabies Immune Globulin (HRIG) Customers List Table 236. Research Programs/Design for This Report Table 237. Authors List of This Report Table 238. Secondary Sources Table 239. Primary Sources List of Figures Figure 1. Human Rabies Immune Globulin (HRIG) Image Figure 2. Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Rabies Immune Globulin (HRIG) Market Size Share 2021 VS 2025 VS 2032 Figure 4. 200IU Image Figure 5. 500IU Image Figure 6. Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Human Rabies Immune Globulin (HRIG) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Category II Exposure Image Figure 9. Category III Exposure Image Figure 10. Global Human Rabies Immune Globulin (HRIG) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Human Rabies Immune Globulin (HRIG) Revenue (2021-2032) & (US$ Million) Figure 12. Global Human Rabies Immune Globulin (HRIG) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2021-2032) Figure 15. Global Human Rabies Immune Globulin (HRIG) Sales (2021-2032) & (K Tons) Figure 16. Global Human Rabies Immune Globulin (HRIG) Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 17. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Human Rabies Immune Globulin (HRIG) Sales YoY (2021-2032) & (K Tons) Figure 19. Europe Human Rabies Immune Globulin (HRIG) Sales YoY (2021-2032) & (K Tons) Figure 20. China Human Rabies Immune Globulin (HRIG) Sales YoY (2021-2032) & (K Tons) Figure 21. Asia (Excluding China) Human Rabies Immune Globulin (HRIG) Sales YoY (2021-2032) & (K Tons) Figure 22. South America, Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales YoY (2021-2032) & (K Tons) Figure 23. Global Human Rabies Immune Globulin (HRIG) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Human Rabies Immune Globulin (HRIG) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2021-2032) Figure 29. Global Human Rabies Immune Globulin (HRIG) Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 30. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2021-2032) Figure 32. Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2021-2032) Figure 35. Global Human Rabies Immune Globulin (HRIG) Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 36. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2021-2032) Figure 38. North America Human Rabies Immune Globulin (HRIG) Revenue Share by Type (2021-2032) Figure 39. North America Human Rabies Immune Globulin (HRIG) Sales Share by Type (2021-2032) Figure 40. North America Human Rabies Immune Globulin (HRIG) Revenue Share by Application (2021-2032) Figure 41. North America Human Rabies Immune Globulin (HRIG) Sales Share by Application (2021-2032) Figure 42. North America Human Rabies Immune Globulin (HRIG) Revenue Share by Country (2021-2032) Figure 43. North America Human Rabies Immune Globulin (HRIG) Sales Share by Country (2021-2032) Figure 44. Europe Human Rabies Immune Globulin (HRIG) Revenue Share by Type (2021-2032) Figure 45. Europe Human Rabies Immune Globulin (HRIG) Sales Share by Type (2021-2032) Figure 46. Europe Human Rabies Immune Globulin (HRIG) Revenue Share by Application (2021-2032) Figure 47. Europe Human Rabies Immune Globulin (HRIG) Sales Share by Application (2021-2032) Figure 48. Europe Human Rabies Immune Globulin (HRIG) Revenue Share by Country (2021-2032) Figure 49. Europe Human Rabies Immune Globulin (HRIG) Sales Share by Country (2021-2032) Figure 50. China Human Rabies Immune Globulin (HRIG) Revenue Share by Type (2021-2032) Figure 51. China Human Rabies Immune Globulin (HRIG) Sales Share by Type (2021-2032) Figure 52. China Human Rabies Immune Globulin (HRIG) Revenue Share by Application (2021-2032) Figure 53. China Human Rabies Immune Globulin (HRIG) Sales Share by Application (2021-2032) Figure 54. Asia Human Rabies Immune Globulin (HRIG) Revenue Share by Type (2021-2032) Figure 55. Asia Human Rabies Immune Globulin (HRIG) Sales Share by Type (2021-2032) Figure 56. Asia Human Rabies Immune Globulin (HRIG) Revenue Share by Application (2021-2032) Figure 57. Asia Human Rabies Immune Globulin (HRIG) Sales Share by Application (2021-2032) Figure 58. Asia Human Rabies Immune Globulin (HRIG) Revenue Share by Country (2021-2032) Figure 59. Asia Human Rabies Immune Globulin (HRIG) Sales Share by Country (2021-2032) Figure 60. SAMEA Human Rabies Immune Globulin (HRIG) Revenue Share by Type (2021-2032) Figure 61. SAMEA Human Rabies Immune Globulin (HRIG) Sales Share by Type (2021-2032) Figure 62. SAMEA Human Rabies Immune Globulin (HRIG) Revenue Share by Application (2021-2032) Figure 63. SAMEA Human Rabies Immune Globulin (HRIG) Sales Share by Application (2021-2032) Figure 64. SAMEA Human Rabies Immune Globulin (HRIG) Revenue Share by Country (2021-2032) Figure 65. SAMEA Human Rabies Immune Globulin (HRIG) Sales Share by Country (2021-2032) Figure 66. Human Rabies Immune Globulin (HRIG) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Human Rabies Immune Globulin (HRIG) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 200IU
  • 500IU
Applications
  • Category II Exposure
  • Category III Exposure
Companies covered
  • Bharat Serum
  • CBPO
  • CNBG
  • CSL Behring
  • Grifols
  • Kamada
  • VINS
  • Shuanglin Bio
  • Sanofi
  • Shanghai RAAS
  • Weiguang Bio
  • Sichuan Yuanda Shuyang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Rabies Immune Globulin (HRIG) Market by Type
  3. 1.2.1 Global Human Rabies Immune Globulin (HRIG) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 200IU
  5. 1.2.3 500IU
  6. 1.3 Human Rabies Immune Globulin (HRIG) Market by Application
  7. 1.3.1 Global Human Rabies Immune Globulin (HRIG) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Category II Exposure
  9. 1.3.3 Category III Exposure
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Human Rabies Immune Globulin (HRIG) Market Dynamics
  1. 2.1 Human Rabies Immune Globulin (HRIG) Industry Trends
  2. 2.2 Human Rabies Immune Globulin (HRIG) Industry Drivers
  3. 2.3 Human Rabies Immune Globulin (HRIG) Industry Opportunities and Challenges
  4. 2.4 Human Rabies Immune Globulin (HRIG) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Rabies Immune Globulin (HRIG) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Region
  3. 3.2.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Rabies Immune Globulin (HRIG) Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Rabies Immune Globulin (HRIG) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Rabies Immune Globulin (HRIG) Sales by Region
  9. 3.4.1 Global Human Rabies Immune Globulin (HRIG) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Rabies Immune Globulin (HRIG) Sales by Region (2021-2026)
  11. 3.4.3 Global Human Rabies Immune Globulin (HRIG) Sales by Region (2027-2032)
  12. 3.4.4 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Manufacturers
  2. 4.1.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Rabies Immune Globulin (HRIG) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Rabies Immune Globulin (HRIG) Sales by Manufacturers
  6. 4.2.1 Global Human Rabies Immune Globulin (HRIG) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Rabies Immune Globulin (HRIG) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Rabies Immune Globulin (HRIG) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Rabies Immune Globulin (HRIG) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Rabies Immune Globulin (HRIG) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Rabies Immune Globulin (HRIG) Manufacturers, Product Type & Application
  13. 4.7 Global Human Rabies Immune Globulin (HRIG) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Rabies Immune Globulin (HRIG) Market CR5 and HHI
  16. 4.8.2 2025 Human Rabies Immune Globulin (HRIG) Tier 1, Tier 2, and Tier 3
5 Human Rabies Immune Globulin (HRIG) Market by Type
  1. 5.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Type
  2. 5.1.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Rabies Immune Globulin (HRIG) Sales by Type
  6. 5.2.1 Global Human Rabies Immune Globulin (HRIG) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Rabies Immune Globulin (HRIG) Sales by Type (2021-2032) & (K Tons)
  8. 5.2.3 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Rabies Immune Globulin (HRIG) Price by Type
6 Human Rabies Immune Globulin (HRIG) Market by Application
  1. 6.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Application
  2. 6.1.1 Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Rabies Immune Globulin (HRIG) Sales by Application
  6. 6.2.1 Global Human Rabies Immune Globulin (HRIG) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Rabies Immune Globulin (HRIG) Sales by Application (2021-2032) & (K Tons)
  8. 6.2.3 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Rabies Immune Globulin (HRIG) Price by Application
7 Company Profiles
  1. 7.1 Bharat Serum
  2. 7.1.1 Bharat Serum Company Information
  3. 7.1.2 Bharat Serum Business Overview
  4. 7.1.3 Bharat Serum Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bharat Serum Human Rabies Immune Globulin (HRIG) Product Portfolio
  6. 7.1.5 Bharat Serum Recent Developments
  7. 7.2 CBPO
  8. 7.2.1 CBPO Company Information
  9. 7.2.2 CBPO Business Overview
  10. 7.2.3 CBPO Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CBPO Human Rabies Immune Globulin (HRIG) Product Portfolio
  12. 7.2.5 CBPO Recent Developments
  13. 7.3 CNBG
  14. 7.3.1 CNBG Company Information
  15. 7.3.2 CNBG Business Overview
  16. 7.3.3 CNBG Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CNBG Human Rabies Immune Globulin (HRIG) Product Portfolio
  18. 7.3.5 CNBG Recent Developments
  19. 7.4 CSL Behring
  20. 7.4.1 CSL Behring Company Information
  21. 7.4.2 CSL Behring Business Overview
  22. 7.4.3 CSL Behring Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 CSL Behring Human Rabies Immune Globulin (HRIG) Product Portfolio
  24. 7.4.5 CSL Behring Recent Developments
  25. 7.5 Grifols
  26. 7.5.1 Grifols Company Information
  27. 7.5.2 Grifols Business Overview
  28. 7.5.3 Grifols Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Grifols Human Rabies Immune Globulin (HRIG) Product Portfolio
  30. 7.5.5 Grifols Recent Developments
  31. 7.6 Kamada
  32. 7.6.1 Kamada Company Information
  33. 7.6.2 Kamada Business Overview
  34. 7.6.3 Kamada Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Kamada Human Rabies Immune Globulin (HRIG) Product Portfolio
  36. 7.6.5 Kamada Recent Developments
  37. 7.7 VINS
  38. 7.7.1 VINS Company Information
  39. 7.7.2 VINS Business Overview
  40. 7.7.3 VINS Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 VINS Human Rabies Immune Globulin (HRIG) Product Portfolio
  42. 7.7.5 VINS Recent Developments
  43. 7.8 Shuanglin Bio
  44. 7.8.1 Shuanglin Bio Company Information
  45. 7.8.2 Shuanglin Bio Business Overview
  46. 7.8.3 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Product Portfolio
  48. 7.8.5 Shuanglin Bio Recent Developments
  49. 7.9 Sanofi
  50. 7.9.1 Sanofi Company Information
  51. 7.9.2 Sanofi Business Overview
  52. 7.9.3 Sanofi Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sanofi Human Rabies Immune Globulin (HRIG) Product Portfolio
  54. 7.9.5 Sanofi Recent Developments
  55. 7.10 Shanghai RAAS
  56. 7.10.1 Shanghai RAAS Company Information
  57. 7.10.2 Shanghai RAAS Business Overview
  58. 7.10.3 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Product Portfolio
  60. 7.10.5 Shanghai RAAS Recent Developments
  61. 7.11 Weiguang Bio
  62. 7.11.1 Weiguang Bio Company Information
  63. 7.11.2 Weiguang Bio Business Overview
  64. 7.11.3 Weiguang Bio Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Weiguang Bio Human Rabies Immune Globulin (HRIG) Product Portfolio
  66. 7.11.5 Weiguang Bio Recent Developments
  67. 7.12 Sichuan Yuanda Shuyang
  68. 7.12.1 Sichuan Yuanda Shuyang Company Information
  69. 7.12.2 Sichuan Yuanda Shuyang Business Overview
  70. 7.12.3 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Product Portfolio
  72. 7.12.5 Sichuan Yuanda Shuyang Recent Developments
8 North America
  1. 8.1 North America Human Rabies Immune Globulin (HRIG) Market Size by Type
  2. 8.1.1 North America Human Rabies Immune Globulin (HRIG) Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Rabies Immune Globulin (HRIG) Sales by Type (2021-2032)
  4. 8.1.3 North America Human Rabies Immune Globulin (HRIG) Price by Type (2021-2032)
  5. 8.2 North America Human Rabies Immune Globulin (HRIG) Market Size by Application
  6. 8.2.1 North America Human Rabies Immune Globulin (HRIG) Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Rabies Immune Globulin (HRIG) Sales by Application (2021-2032)
  8. 8.2.3 North America Human Rabies Immune Globulin (HRIG) Price by Application (2021-2032)
  9. 8.3 North America Human Rabies Immune Globulin (HRIG) Market Size by Country
  10. 8.3.1 North America Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Rabies Immune Globulin (HRIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Rabies Immune Globulin (HRIG) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Human Rabies Immune Globulin (HRIG) Market Size by Type
  2. 9.1.1 Europe Human Rabies Immune Globulin (HRIG) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Rabies Immune Globulin (HRIG) Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Rabies Immune Globulin (HRIG) Price by Type (2021-2032)
  5. 9.2 Europe Human Rabies Immune Globulin (HRIG) Market Size by Application
  6. 9.2.1 Europe Human Rabies Immune Globulin (HRIG) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Rabies Immune Globulin (HRIG) Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Rabies Immune Globulin (HRIG) Price by Application (2021-2032)
  9. 9.3 Europe Human Rabies Immune Globulin (HRIG) Market Size by Country
  10. 9.3.1 Europe Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Rabies Immune Globulin (HRIG) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Human Rabies Immune Globulin (HRIG) Market Size by Type
  2. 10.1.1 China Human Rabies Immune Globulin (HRIG) Revenue by Type (2021-2032)
  3. 10.1.2 China Human Rabies Immune Globulin (HRIG) Sales by Type (2021-2032)
  4. 10.1.3 China Human Rabies Immune Globulin (HRIG) Price by Type (2021-2032)
  5. 10.2 China Human Rabies Immune Globulin (HRIG) Market Size by Application
  6. 10.2.1 China Human Rabies Immune Globulin (HRIG) Revenue by Application (2021-2032)
  7. 10.2.2 China Human Rabies Immune Globulin (HRIG) Sales by Application (2021-2032)
  8. 10.2.3 China Human Rabies Immune Globulin (HRIG) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Rabies Immune Globulin (HRIG) Market Size by Type
  2. 11.1.1 Asia Human Rabies Immune Globulin (HRIG) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Rabies Immune Globulin (HRIG) Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Rabies Immune Globulin (HRIG) Price by Type (2021-2032)
  5. 11.2 Asia Human Rabies Immune Globulin (HRIG) Market Size by Application
  6. 11.2.1 Asia Human Rabies Immune Globulin (HRIG) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Rabies Immune Globulin (HRIG) Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Rabies Immune Globulin (HRIG) Price by Application (2021-2032)
  9. 11.3 Asia Human Rabies Immune Globulin (HRIG) Market Size by Country
  10. 11.3.1 Asia Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Rabies Immune Globulin (HRIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Rabies Immune Globulin (HRIG) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Rabies Immune Globulin (HRIG) Market Size by Type
  2. 12.1.1 SAMEA Human Rabies Immune Globulin (HRIG) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Rabies Immune Globulin (HRIG) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Rabies Immune Globulin (HRIG) Price by Type (2021-2032)
  5. 12.2 SAMEA Human Rabies Immune Globulin (HRIG) Market Size by Application
  6. 12.2.1 SAMEA Human Rabies Immune Globulin (HRIG) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Rabies Immune Globulin (HRIG) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Rabies Immune Globulin (HRIG) Price by Application (2021-2032)
  9. 12.3 SAMEA Human Rabies Immune Globulin (HRIG) Market Size by Country
  10. 12.3.1 SAMEA Human Rabies Immune Globulin (HRIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Rabies Immune Globulin (HRIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Rabies Immune Globulin (HRIG) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Rabies Immune Globulin (HRIG) Value Chain Analysis
  2. 13.1.1 Human Rabies Immune Globulin (HRIG) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Rabies Immune Globulin (HRIG) Production Mode & Process
  6. 13.2 Human Rabies Immune Globulin (HRIG) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Rabies Immune Globulin (HRIG) Distributors
  9. 13.2.3 Human Rabies Immune Globulin (HRIG) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst